<p>Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights</p>-Reference-Cited by-同舟云学术

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights

Published:2020-09 Issue: Volume:Volume 13 Page:301-313
ISSN:1178-6965
Container-title:Journal of Asthma and Allergy
language:en
Short-container-title:JAA

Author:

Menzella Francesco^ORCID,Ruggiero Patrizia,Ghidoni Giulia,Fontana Matteo,Bagnasco Diego^ORCID,Livrieri Francesco,Scelfo Chiara^ORCID,Facciolongo Nicola

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference96 articles.

1. Severe Asthma in Primary Care: Identification and Management

2. Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma

3. Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management

4. Eosinophil Development, Regulation of Eosinophil-Specific Genes, and Role of Eosinophils in the Pathogenesis of Asthma

5. IL-5 and eosinophilia

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated eosinophils in early life impair lung development and promote long-term lung damage;Mucosal Immunology;2024-06

2. Evidencia terapéutica del mepolizumab en la granulomatosis eosinofílica con poliangeítis: una revisión exploratoria;Revista Colombiana de Reumatología;2024-02

3. The UDP-glucose/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation;International Immunology;2023-12-18

4. The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy;The Journal of Allergy and Clinical Immunology: In Practice;2023-09

5. Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients;Clinical Immunology;2023-08